Setlow J K, McCarthy D, Clayton N L
J Bacteriol. 1982 Sep;151(3):1358-62. doi: 10.1128/jb.151.3.1358-1362.1982.
The plasmid pNov2, carrying a cloned chromosomal marker conferring resistance to at least 2.5 micrograms of novobiocin per ml, was constructed with a new Haemophilus influenzae cloning vehicle, pDM2. The novobiocin marker of pNov2 was not normally expressed, but in Rec+ cells approximately one in 10(4) cells in a culture of a transformant became novobiocin resistant, a frequency about four orders of magnitude higher than the spontaneous mutation frequency. Variants of such cells that had lost the plasmid were also novobiocin resistant. Since Rec- cultures bearing pNov2 showed novobiocin resistance only at the normal mutation frequency, we concluded that the Rec+ novobiocin-resistant transformants arose because of a rare recombination between plasmid and chromosome in which the chromosome acquired the novobiocin marker from the plasmid. Evidence is presented that novobiocin sensitivity is dominant over this particular novobiocin resistance marker.
携带一个克隆的染色体标记、赋予每毫升至少2.5微克新生霉素抗性的质粒pNov2,是用一种新的流感嗜血杆菌克隆载体pDM2构建的。pNov2的新生霉素标记通常不表达,但在Rec⁺细胞中,转化体培养物中大约每10⁴个细胞中有一个变成对新生霉素有抗性,这个频率比自发突变频率高约四个数量级。丢失了质粒的这类细胞的变体也对新生霉素有抗性。由于携带pNov2的Rec⁻培养物仅在正常突变频率下表现出对新生霉素的抗性,我们得出结论,Rec⁺新生霉素抗性转化体的出现是由于质粒与染色体之间罕见的重组,其中染色体从质粒获得了新生霉素标记。有证据表明,新生霉素敏感性相对于这个特定的新生霉素抗性标记是显性的。